Perennial second private to public fund fully subscribed

9 October 2020
| By Chris Dastoor |
image
image
expand image

Perennial’s Private to Public Opportunities fund No.2 fund (PPP2) has closed its capital raising fully subscribed, raising $125 million. 

The launch of the fund by Perennial followed the success of its first private companies fund (PPP), and the new strategy which announced in September, would employ the same investment strategy as its predecessor fund with the aim to generate superior returns over a five-year period. 

According to FE Analytics, the first Private to Public Opportunity  fund had returned 31.89% since inception on 16 August, 2019, to 31 August, 2020. 

The fund aimed to invest in high-growth equity opportunities through an actively managed portfolio of 30-45 unlisted, pre-IPO and listed Australian companies. 

Perennial said it had already identified several private and pre-IPO investments for the new fund, with the deployment of capital to commence immediately.  

Andrew Smith, Perennial head of smaller companies and microcaps, said: “We appreciate the support from investors for our initial PPP fund, as well as the strong demand experienced for PPP2. We are very pleased to reach the maximum fund target size of $125 million for our second PPP fund”. 

Brendan Lyons, Perennial head of private investments, said investors had been supportive of the fund’s investment strategy, which focused on the Last Private Offer (LPO) undertaken by founder-led companies prior to an IPO or other liquidity event. 

“Our systematic process, coupled with a large and growing pipeline of private opportunities, provides a diversified investment exposure which is otherwise difficult to access,” Lyons said. 

“In addition, increased volatility in global equity markets this year has prompted many investors to seek out alternate sources of return.” 

Ryan Sohn, deputy portfolio manager, said two of the initial investments included e-commerce businesses with significant scale as well as a health technology company with unique intellectual property.  

“We have followed the growth of these businesses for a significant period of time and are delighted to now be part of the journey with them,” Sohn said. 

Some of the businesses the first fund invested in included soft tissue regeneration business Aroa Biosurgery, diagnostic testing business Atomo Diagnostics and lung imaging technology firm 4D Medical, which all became listed on the Australian Securities Exchange (ASX) this year.  

Performance of the Perennial Private to Public Opportunity fund since inception to 31 August 2020 

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

GG

So shareholders lose a dividend plus have seen the erosion of value. Qantas decides to clawback remuneration from Alan ...

2 months 1 week ago
Denise Baker

This is why I left my last position. There was no interest in giving the client quality time, it was all about bumping ...

2 months 1 week ago
gonski

So the Hayne Royal Commission has left us with this. What a sad day for the financial planning industry. Clearly most ...

2 months 1 week ago

A Sydney-based financial adviser has been banned from providing financial services in the interest of consumer protection after failing to act on conduct concerns. ...

3 weeks 3 days ago

ASIC has cancelled the AFSL of a $250 million Sydney fund manager, one of two AFSL cancellations announced by the corporate regulator....

3 weeks 1 day ago

Having divested its advice business in August, AMP is undergoing restructuring in at least four other departments amid a cost simplification program....

2 weeks 5 days ago